Similarly, there was a reduction in the frequency of both CD8+ and CD4+ T cells in tumor-infiltrating lymphocytes (TILs) in the (OT-II-Th9 + LB-100) group as compared to Th9 group (Fig. 6e). The gene discussed is CD8A; the disease is neoplasm.